Cancer Survivors Program

The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.

Inclusion Criteria: * The patient understands the information provided and agrees to participate in the study. * Age 18 years or older. * Histologically confirmed invasive breast cancer or invasive prostate cancer. * Completion of the acute phase of curative oncological therapy: * for breast cancer: curative surgery performed + completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy, if indicated * for prostate cancer: completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy * The patient is available for follow-up within 12 months of enrollment in the study. Exclusion Criteria: * Active ongoing oncological therapy (except for (i) adjuvant hormone therapy, (ii) adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), (iii) adjuvant immunotherapy) * Neoadjuvant/adjuvant therapy did not include chemotherapy (breast cancer). * Recurrence of cancer * Metastatic disease * History of other primary malignancy (except for non-melanoma skin cancer)